Corporate Profile for Interneuron Pharmaceuticals, dated March 22, 1996.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services. These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company, Prodigy, Comtex, and many others. -0- Published date: March 22, 1996 Company name: Interneuron interneuron /in·ter·neu·ron/ (-noor´on) 1. a neuron between the primary sensory neuron and the final motoneuron. 2. Pharmaceuticals Inc. Address: 99 Hayden Ave. Lexington, MA 02173 Telephone No.: 617-861-8444 Chief Executive Officer: Glenn L. Cooper, M.D. Chief Financial Officer: Thomas F. Farb Investor Relations Contact: William B. Boni Business number: 617/861-8444 Public Relations Contact: William B. Boni Business number: 617/861-8444 Trading symbol: IPIC IPIC Intellectual Property Institute of Canada IPIC Indianapolis Private Industry Council IPIC International Petroleum Investment Co (Abu Dhabi) IPIC Inventory Price Index Computation IPIC Information Processing Interagency Conference (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on ) Industry: Biopharmaceuticals Company description: Interneuron Pharmaceuticals Inc. is engaged in the development and commercialization of innovative products primarily for the treatment of neurological and behavioral disorders. Through four subsidiaries, Intercardia Inc., Progenitor Inc., Transcell Technologies Inc. and InterNutria Inc., Interneuron is developing products and technologies related to cardiovascular disease, gene therapy, stem cell biology, carbohydrate-based drug discovery and drug transport, and nutritional products. A key business objective for Interneuron is the accelerated development of central nervous system products with significant market potential. Interneuron is also pursuing a strategy of diversification within the healthcare field by acquisition, in-licensing or establishing subsidiaries to conduct research and development in specializing areas. Interneuron's product portfolio and target indications include Redux (dexfenfluramine) for obesity, citicoline for stroke, bucindolol for congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. (through Intercardia), pagoclone for anxiety, low-dose melatonin melatonin: see pineal gland. melatonin Hormone secreted by the pineal gland of most vertebrates. It appears to be important in regulating sleeping cycles; more is produced at night, and test subjects injected with it become sleepy. for insomnia and PMS (Pantone Matching System) A color matching system that has a unique number assigned to more than 500 different colors and shades. This standard for the printing industry has been built into many graphics and desktop publishing programs to ensure color accuracy. Escape for pre-mestrual syndrome. Redux received an FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. advisory committee recommendation for approval in late 1995, and citicoline and bucindolol are in advanced stages of clinical testing. The company's development and marketing partners include American Home Products for Redux and Astra-Merck for bucindolol. CONTACT: Interneuron Pharmaceuticals Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion